Cite
HARVARD Citation
Kindler, H. et al. (n.d.). Preliminary Clinical Data From Ongoing Phase 2 Study With Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors or Hematologic Malignancies. European journal of cancer. pp. S31-S32. [Online].